Literature DB >> 29690661

[Guidenline for diagnosis and treatment of Alk and Ros1 positive non-small cell lung cancer in China].

X C Zhang, S Lu, L Zhang, M L Liao, C L Wang, Y Cheng, G D Li, S J Mok, C Huang, X Q Liu, J Wang, M Z Wang, Y P Zhang, J Y Zhou, X J Zhou, X Y Zhou, D M Lin, J J Yang, Y Song, C P Hu, K Wang, Y He, H Li, W Z Zhong, Y L Wu.   

Abstract

Entities:  

Year:  2018        PMID: 29690661     DOI: 10.3760/cma.j.issn.0529-5807.2018.04.003

Source DB:  PubMed          Journal:  Zhonghua Bing Li Xue Za Zhi        ISSN: 0529-5807


× No keyword cloud information.
  4 in total

1.  ALK detection in lung cancer: identification of atypical and cryptic ALK rearrangements using an optimal algorithm.

Authors:  Yuanyuan Liu; Shafei Wu; Xiaohua Shi; Zhiyong Liang; Xuan Zeng
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-03       Impact factor: 4.553

Review 2.  Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review.

Authors:  Zhe Zhang; Sen Yang; Yanfang Ma; Hanqiong Zhou; Xuan Wu; Jing Han; Jiabao Hou; Lidan Hao; Jonathan D Spicer; Young Wha Koh; Mariano Provencio; Noemi Reguart; Tetsuya Mitsudomi; Qiming Wang
Journal:  Transl Lung Cancer Res       Date:  2021-06

3.  Evaluation of the reporting quality of clinical practice guidelines on lung cancer using the RIGHT checklist.

Authors:  Yongjie Yang; Jingli Lu; Yanfang Ma; Chen Xi; Jian Kang; Qiwen Zhang; Xuedong Jia; Kefeng Liu; Shuzhang Du; Florian Kocher; Andreas Seeber; Cesare Gridelli; Mariano Provencio; Nobuhiko Seki; Yusuke Tomita; Xiaojian Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-06

4.  Clinical evaluation of the effectiveness of fusion-induced asymmetric transcription assay-based reverse transcription droplet digital PCR for ALK detection in formalin-fixed paraffin-embedded samples from lung cancer.

Authors:  Yuanyuan Liu; Shafei Wu; Xiaohua Shi; Linping Lu; Lingxiang Zhu; Yong Guo; Li Zhang; Xuan Zeng
Journal:  Thorac Cancer       Date:  2020-06-16       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.